Adherence Current status, and how distress may be key to progress

Slides:



Advertisements
Similar presentations
Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Advertisements

Inappropriate clopidogrel adherence explains stent related adverse outcomes Leonardo Tamariz, MD, MPH University of Miami.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Progress with the literature reviews for the CHOICE programme Chris Dickens.
Introduction Approximately 1 in 3 of adults, have cardiovascular disease vascular/metabolic risk factors such as hypertension, dyslipidemia, and diabetes;
1 Assessing and Improving ARV Adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.
Medication Adherence The following module is designed as a basic overview of medication adherence for providers of healthcare, particularly those in a.
Functional Impairment and Depressive Symptoms: Mitigating Effects of Trait Hope Jameson K. Hirsch, Ph.D. 1,2, S. Kaye, B.S. 1, & Jeffrey M. Lyness, M.D.
Exam Review Health Psychology. Response Cost Behavior decreases due to something being removed from the situation.
PHCL 436 Lecture two. Objectives  The role of cognition in influencing adjustment to chronic conditions  What is medication adherence, prevalence, reasons,
Chapter 14: Anxiety & Depression in the Older Adult.
M. Ekstrand 1,2,3, A. Shet 2,4, S. Chandy 4, G. Singh 4, R. Shamsundar 4, V. Madhavan 5, S. Saravanan 5, N. Kumarasamy 5 1 University of California, San.
Assessment and Management of Depression, Anxiety, and Alcohol Problems in Primary Care: The BHL Program VISN 4 MIRECC VA Philadelphia University of Pennsylvania.
Michael J. Mugavero, MD, MHSc Associate Professor of Medicine University of Alabama at Birmingham Birmingham, Alabama Elements of the Care Continuum FORMATTED:
Better Patient Adherence: Why patients don’t adhere and what we can do about it (maybe) Frank Doyle, PhD RCSI Royal College of Surgeons in Ireland Coláiste.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Do Decision Aids Promote Shared Decision-Making for Prostate Cancer Screening? Alex Krist MD Steven Woolf MD MPH Robert Johnson PhD Department of Family.
Chronic Disease Management Mitigates the Relationship between Literacy and Health Outcomes Darren A. DeWalt, MD, MPH RWJ Clinical Scholars Program Division.
The Impact of Disability on Depression Among Individuals With COPD Patricia P. Katz, PhD ; Laura J. Julian, PhD ; Theodore A. Omachi, MD, MBA ; Steven.
Comorbidity and Multimorbidity: Measurement and Interventions Holly M. Holmes, MD, MS Dept of General Internal Medicine.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Clinical Quality Improvement: Achieving BP Control
CLINICAL TRIALS.
Learning objectives Review HIV treatment goals
Fracture Liaison Service Database
Psychological treatment of Schizophrenia
Increasing Utilization of Well Child Exams
1University of Kentucky, Lexington, Kentucky
MEP Interest Group on Brain, Mind and Pain
Primary Prevention of Cardiovascular Disease (CVD) Events with Statins
DATA COLLECTION METHODS IN NURSING RESEARCH
Hypertension November 2016
Sameera Ansari1, Dr Hassan Hosseinzadeh1,
Using Technology to Support Evidence Based Practice
Research where it is most needed National Respiratory Strategy
Jessica Haberer, MD, MS July 24, 2017
THE RELATIONSHIP BETWEEN SOCIAL SUPPORT, ACES, AND CHRONIC PAIN
Suicide Mortality Following VA Irregular Discharges:
Effects of Educating URI General Education Students on Physical Activity, Exercise, and Disease Prevention and Maintenance Julie Gastall, Department.
Believed discrimination occurred because of their:
Don’t Nudge Me: The Limits of Behavioral Economics in Medicine
Goal-directed Treatment for Osteoporosis
Chapter 7 The Hierarchy of Evidence
תכנית נאור נטילת אחריות עצמית על טיפול תרופתי
Ageing with ideal cardiovascular risk factors
Nursing-Sensitive Quality Indicators And Safety Initiatives
John de Wit1,2, Dean Murphy2,3, Luxi Lal4,5,6, Jennifer Audsley5,7, Christopher K. Fairley8,9, Mark Stoove4,10, Norm Roth11, Richard Moore12, Ban K.
Matthew H. Liang, MD Malcolm P. Rogers, MD Ira R. Katz, MD, PhD
Elements of the Care Continuum
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
اتجاهات أنماط المرض بين السكان. المراحل الأربع للتحول الوبائى.
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
MECIR: the bits that reviewers keep getting wrong!
So you want to measure adherence…
Hepatitis B Vaccination Assessment Adults Aged Years National Health Interview Survey, 2000 Gary L. Euler, DrPH1, Hussain Yusuf, MBBS2, Shannon.
Non-Pharmacological Therapies, Chronic Pain and Opioid Addictions
and Prevent 100 Million Deaths from Cardiovascular Disease
Achieving and Sustaining Behavior Change to Benefit Older Adults:
Streamlined Data Collection
The Method Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018.
Hypertension November 2016
National Institute on Aging
Clair Huckerby Consultant Pharmacist
Effectiveness of a healthy lifestyle clinician in addressing the health risk behaviours of clients of a community mental health service: an RCT Caitlin.
Smoking Cessation.
Stakeholder engagement and research utilization: Insights from Namibia
Clare Lewis Deputy Chief Nursing Officer Community
How to Measure Quality of Life
Registered Nurse’s Use of HIT, 2006: Findings from a National Survey
Presentation transcript:

Adherence Current status, and how distress may be key to progress Don Edmondson, PhD, MPH, with a lot of help from Ian Kronish, MD, MPH RCCN Meeting, Bethesda, 2018

Medication Adherence is Crucial “Drugs don’t work in patients who don’t take them” Surgeon General Koop, 1985 Medication Adherence is Crucial 26% difference in health outcomes between high and low adherers DiMatteo, Med Care, 2004 Key Point: Explain how to refer to ABPM BCT: Instruction on how to perform the behavior Intervention function: training 125,000 deaths and $289 billion in costs per year Viswanathan, Ann Intern Med, 2012 Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Lots of Research Not a Lot of Progress Cochrane review 2014 182 RCTs of adherence interventions Only 5 interventions reported impact on adherence and outcomes “Current methods…are mostly complex and not very effective” Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018 Kronish & Moise. JAMA Intern Med, 2017; Nieuwlatt et al. Cochrane Database Sys Rev 2014

In systematic reviews, 15-25% of CVD patients screen positive for CVD-related PTSD Those who screen positive are at twice the risk of secondary CVD events and mortality Mechanisms include autonomic, immune, and behavioral pathways Adherence is particularly compromised The underappreciated role of distress after life-threatening medical events Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018 Edmondson et al., 2011, 2012; Sumner et al., 2017 3

Enduring somatic threat PTSD due to CVD events is different It’s about present and future risk (not past) From a threat in the body Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018 Meli et al, 2017

Distress and non-adherence Adherence is associated with secondary risk But patients who are most distressed by the index event are least likely to adhere Those who screen positive are twice as likely to be nonadherent—not just because of PTSD (PTSD due to other types of events was not associated with adherence) Distress and non-adherence Taggart Wasson et al., 2018 Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Patients avoid medications that remind them of risk We first saw that patients with greater anxiety sensitivity were less adherent In particular, those who reported interoceptive sensitivity and catastrophizing interpretations of somatic signals We considered implicit measures, but decided to just ask them Those with high distress reported skipping medications because they reminded them of risk Patients avoid medications that remind them of risk Alcantara et al., 2014; Husain et al, 2018; Monane et al., 2018 Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

It’s not just about medications Patients also report avoiding physical activity for fear of increased HR We have observed autonomic hyperreactivity to physiological and cognitive threat cues in ACS patients, and interoceptive threat bias increases 24-hr heart rate at 1 month post-ACS It’s not just about medications Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018 Monane et al., 2018

Conceptual model with candidate mechanisms Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Rather than a “teachable moment,” perhaps a time for reducing risk perceptions Focus on positive affect/meaning rather than risk reduction to motivate behavior change Clarify the limitations of interoception for identifying acute exacerbations Exposure-based interventions paired with health behaviors as stress reduction may be beneficial Implications Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Discussion Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Thank you. Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Is There a “Best” Adherence Measure? Adherence is a multidimensional behavior Measures do not assess the same behavior (e.g., refill ≠ electronic adherence) Different measures may be needed to measure different adherence behaviors Is There a “Best” Adherence Measure? Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Recommended Self-Report Questionnaires (N=24; more than 1 per respondent possible) Name of Scale Frequency Voils Adherence Questionnaire (3-items) 4 Wilson’s HIV Adherence Questionnaire (3-items) Morisky Scale (unspecified; 8 item; 4-item) “Don’t use” 4, 2, 1 1 McHorney’s Adherence Estimator (3-items) 3 Hill-Bone Questionnaire, (8-items) 2 “Weinman’s Questionnaire”/BMQ (10-items) Visual Analog Scale (1-item) “Ability to adhere” Likert Scale with 5-6 options (1-item) Haynes et al. 1980 Tablets missed per day/wk/mo (3-items) Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Reasons for Recommending Top SRQs Name of Scale Reasons Voils Adherence Questionnaire Assesses behavior and reasons separately Wilson’s HIV Adherence Questionnaire Validated with electronic adherence Validated with outcomes (HIV viral load) Rigorous development with cognitive testing Prevents ceiling effects Ease of use Free Morisky Scale “Don’t use” Validated Commonly used Allows for variability Combines attitudes and reasons for nonadherence McHorney’s Adherence Estimator Validated against claims refill data Face validity Designed for clinical use Ease of use including on-line platform Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Recommended Electronic Adherence Devices (N=24; more than 1 per respondent possible) Name of Device Frequency Reasons MEMS 6 long track-record well-validated well-accepted by adherence community Wisepill 3 wireless, enabling just-in-time interventions and remote data collection AdhereTech 1 approved by institution (VA) eCAPS affordable resemble typical pill bottles wireless version Homemade devices (e.g., Ekstrand’s Tel-Me-Box) No specific brand “choice depends on lots of factors” Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Medication Nonadherence is Common 30% 50% 70% All of the above What percent of patients are non-adherent to chronic disease medications? Myth #1: Individuals only adhere to medications 50% of the time Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018 Gellad et al. Pharmacoepidemiol Drug Saf, 2017

Prevalence of Non-adherence Depends on Specific Adherence Behavior 15-20% Never initiate Miss >20% of doses Discontinue within 1 year 30-70% 30-70% Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018 DiMatteo Med Care 2004; Dunbar-Jacob J Clin Epidemiol 2001; DiMatteo Med Care 2002

Few Studies Use a Mechanistic Approach Conducted a systematic review of NIH-funded trials with medication adherence as an outcome (inception – June 2016) Only 3% (2 of 44) of trials incorporated tests of hypothesized mechanisms of behavior change by which interventions improve medication adherence Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018 Edmondson et al. Behav Res Ther. 2017

Early Discontinuation Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018 Late Initiation, Good Implementation Good Initiation, Poor Implementation Good Initiation, Good Implementation, Early Discontinuation Vrijens et al. Br J Clin Pharmacol. 2012

Decrease in adherence due to discontinuation Blaschke et al. Annu Rev Pharmacol Toxicol. 2012 Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018

Focus of many behavioral interventions Decrease in adherence due to discontinuation Blaschke et al. Annu Rev Pharmacol Toxicol. 2012 Donald Edmondson, "Achieving and Sustaining Behavior Change to Benefit Older Adults" Dec 6-7, 2018